Oncology

Filter

Recent Developments in NMIBC Research

9 Mins

January 2026

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these cases…

Sponsored content: ADC-IO combination in comorbid patients with advanced urothelial cancer

This promotional material is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd…

Paradigm Changes in Prostate Cancer Management in Recent Years

This article discusses changes in the advanced prostate cancer landscape over the past decade that have induced a paradigm shift in…

Hydrogel Urothelial Cancer Therapies

Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…

How Targeted Approaches Are Transforming Management of Advanced EGFR-Mutant Lung Cancer

Overcoming Resistance: How Targeted Approaches Are Changing Management of Advanced EGFR-Mutant Lung Cancer and Pavingthe Way for Precision…

Advances in 2L ER+/HER2− mBC therapy

Despite advances in first-line endocrine therapy (ET) plus cyclin-dependent 4/6 kinase inhibitors (CDK4/6i) in oestrogen receptor-positive…

Inside the Cancer Vaccine Revolution: Interview with Lennard Lee

I’m a clinical academic, which is quite a rare breed of doctor, because what I’m doing, along with other clinical academics, is being…

Endometrial Cancer Research in 2024

Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been associated…

31 Oct 2024

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.

Loading posts...

« Previous 1 2 3 4 5 … 31 Next »